News
1 min read

Zaka VC Invests in DeepSeq.AI to Transform AI-Based Protein Drug Discovery

Published on
January 12, 2026

Excited to announce that Zaka VC has invested in DeepSeq! As the 2026 JPM Biotech conference kicks off, with a focus on what AI can do for the industry, DeepSeq will do its part by transforming AI-based protein drug discovery using hyperscaled data.

Read more:

https://www.einpresswire.com/article/879998435/zaka-vc-invests-in-deepseq-ai-to-transform-ai-based-protein-drug-discovery

Contact us today to learn more about how DeepSeq.AI can empower you

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.